| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Ellen M Hancock last filed a Form 4 in May 2018, as Director at CL. Ellen M Hancock's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 206,756 shares of CL. The CL filings lean toward selling, a net 9,733 shares.
Ellen M Hancock has 3 Form 4 filings on record from August 2017 to May 2018, all as Director at Colgate Palmolive (CL), 2017–2018.
The 7 reported transactions were 2 option exercises, 2 open-market sales, 1 stock award and 1 option or other derivative award, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 2 sales worth about $710K.
The largest open-market sale was 5,057 shares of CL at an average $71.91 on August 1, 2017, about $364K.
Shares as reported in the last Form 4 for each company; the most recent is from May 2018. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.